ÂÜÀòÂÒÂ×

Dolo Diaz currently serves as Global Head and Senior Vice President of Drug Discovery and Development Sciences at Altos Labs since February 2023. Previously, Dolo held various leadership roles at Denali Therapeutics from September 2016 to March 2023, including Senior Vice President and Vice President of Development Sciences, focusing on toxicology, pathology, nonclinical operations, and clinical pharmacology. Dolo also worked as Senior Director and Director of Safety Assessment at Denali. Prior experience includes serving as Associate Director of the Discovery Toxicology Group at Genentech, along with roles at Eurofins and Fred Hutchinson Cancer Research Center as a Senior Scientist and Postdoctoral Research Fellow, respectively. Dolo holds a PhD in Molecular Toxicology from the University of Washington and a Bachelor's degree in Pharmacy from Universidad de Santiago de Compostela.